Diabetes Research and Clinical Practice
Volume 74, Issue 2, Supplement , Pages S17-S19 , 30 November 2006

How to start insulin treatment: Earlier or delayed insulin therapy

References 

  1. UK Prospective Study Group. Prospective Diabetes Study 16. Overview of 6 years’ therapy of type II diabetes: a progressive disease. Diabetes. 1995;44:1249–1258
  2. Poitout V, Robertson RP. An integrated view of beta-cell dysfunction in type-II diabetes. Annu. Rev. Med. 1996;47:69–83
  3. Segall L, Lameloise N, Assimacopoulos-Jeannet F, Roche E, Corkey P, Thumelin S, et al. Lipid rather than glucose metabolism is implicated in altered insulin secretion caused by oleate in INS-1 cells. Am. J. Physiol. 1999;277:E521–E528
  4. Gremlich S, Bonny C, Waeber G, Thorens B. Fatty acids decrease IDX-1 expression in rat pancreatic islets and reduce GLUT2, glucokinase, insulin, and somatostatin levels. J. Biol. Chem. 1997;272:30261–30269
  5. Unger RH. Lipotoxicity in the pathogenesis of obesity-dependent NIDDM. Genetic and clinical implications. Diabetes. 1995;44:863–870
  6. Butler AE, Janson J, Bonner-Weir S, Ritzel R, Rizza RA, Butler PC. β-cell deficit and increased beta cell apoptosis in humans with type 2 diabetes. Diabetes. 2003;52:102–110
  7. Marshak S, Leibowitz G, Bertuzzi F, Socci C, Kaiser N, Gross DJ, et al. Impaired β-cell functions induced by chronic exposure of cultured human pancreatic islets to high glucose. Diabetes. 1999;48:1230–1236
  8. Shichiri M, Kishikawa H, Ohkubo Y, Wake N. Long-term results of the kumamoto study on optimal diabetes control in type 2 diabetic patients. Diabetes Care. 2000;23(Suppl. 2):B21–B29
  9. Khaw K-T, Wareham N, Luben R, Bingham S, Oakes S, Welch A, et al. Glycosylated haemoglobin, diabetes and mortality in men in Norfolk cohort of European Prospective Investigation of Cancer and Nutrition (EPIC-Norfolk). BMJ. 2001;322:15–18
  10. Davidson MB. Early insulin therapy for type 2 diabetic patients: more cost than benefit. Diabetes Care. 2005;28:222–224
  11. Malmberg K, Ryden L, Hamstent A, Herlitz J, Waldenström A, Wedel H on behalf of the DIGAMI study group. Effects of insulin treatment on cause-specific one-year mortality and morbidity in diabetic patients with acute myocardial infarction: the DIGAMI Study Group. Eur. Heart J. 1996;17:1337–1344
  12. DCCT/EDIC Research Group. Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy. N. Engl. J. Med. 2000;342:381–389
  13. Brown JB, Nichols GA. Slow response to loss of glycemic control in type 2 diabetes mellitus. Am. J. Manag. Care. 2003;9:213–217
  14. Brown JB, Nichols GA, Perry A. The burden of treatment failure in type 2 diabetes. Diabetes Care. 2004;27:1531540
  15. Ilkova H, Glaser B, Tunckale A, Bagriacik N, Cerasi E. Induction of long-term glycemic control in newly diagnosed type 2 diabetic patients by transient intensive insulin treatment. Diabetes Care. 1997;20:1353–1356
  16. Li Y, Xu W, Liao Z, Yao B, Chen X, Huang Z, et al. Induction of long-term glycemic control in newly diagnosed type 2 diabetic patients is associated with improvement of β-cell function. Diabetes Care. 2004;27:2597–2602
  17. Ryan EA, Imes S, Wallace C. Short-term intensive insulin therapy in newly diagnosed type 2 diabetes. Diabetes Care. 2004;27:1028–1032
  18. Peters AL, Davidson MB. Maximal dose glyburide therapy in markedly symptomatic patients with type 2 diabetes: a new use for an old friend. J. Clin. Endocrinol. Metab. 1996;81:2423–2427
  19. Alvarsson M, Sundkvist G, Lager I, Henricsson M, Berntorp K, Fernqvist-Forbes E, et al. Beneficial effects of insulin versus sulphonylurea on insulin secretion and metabolic control in recently diagnosed type 2 diabetic patients. Diabetes Care. 2003;26:2231–2237
  20. Ovalle F, Bell DSH. Effect of rosiglitazone versus insulin on the pancreatic β-cell function of subjects with type 2 diabetes. Diabetes Care. 2004;27:2585–2589
  21. Buteau J, El-Assaad W, Rhodes C, Rosenberg L, Joly E, Prentki M. Glucagon-like peptide-1 prevents beta cell glucolipotoxicity. Diabetologia. 2004;47:806–815

PII: S0168-8227(06)00256-7

doi: 10.1016/j.diabres.2006.06.008

Diabetes Research and Clinical Practice
Volume 74, Issue 2, Supplement , Pages S17-S19 , 30 November 2006

Article Tools